What were the primary drivers of revenue growth in Q1 2015?

Revenue growth was primarily driven by an 8% increase in total revenues to $842.7 million. Specifically, clearing and transaction fees, which constitute the largest portion of revenue, grew by 9% to $708.2 million. This increase was largely attributable to a 10% rise in total contract volume, especially in interest rate, foreign exchange, and energy products, reflecting heightened market activity due to factors like changing interest rate expectations and crude oil price volatility.

How did CME Group manage its expenses during the quarter?

Total expenses increased by 4% to $335.4 million, a more moderate increase compared to revenue growth, leading to an improved operating margin of 60.2%. Key factors influencing expense changes included a foreign currency exchange rate fluctuation, a net reduction in a litigation accrual, and costs associated with a reorganization plan. Notably, depreciation and amortization, as well as salaries and benefits, saw decreases due to prior year events and headcount adjustments.

What is the company's financial health and liquidity position based on this report?

CME Group maintained a strong liquidity position, with cash and cash equivalents increasing to $1.7 billion at March 31, 2015. Operating cash flow saw a healthy increase of 9% to $418.9 million. The company also strengthened its capital structure by issuing new debt and repurchasing existing notes. Its credit ratings remained strong (A1+/AA- from S&P, P1/Aa3 from Moody's), indicating good financial health and access to capital markets.

Are there any significant legal or contingent liabilities that investors should be aware of?

While CME Group is involved in various legal and regulatory matters, the company believes that the resolution of these matters, individually, will not have a material impact on its consolidated financial position or results of operations. The report mentions ongoing litigation regarding alleged patent infringement and a CFTC suit concerning confidential customer information. However, the company has accrued amounts for probable and estimable legal and regulatory matters, which were $3.5 million at March 31, 2015. The company also has intellectual property indemnification obligations, but potential future claims cannot be estimated.

CME 10-Q Quarterly Report Q1 FY2015 — Revenue, Net Income, EPS

Summary

CME Group Inc. reported solid financial results for the first quarter of 2015, demonstrating revenue growth and improved profitability compared to the same period in the prior year. Total revenues increased by 8% to $842.7 million, driven primarily by a 9% increase in clearing and transaction fees, which benefited from a 10% rise in contract volume. This increase in volume was fueled by heightened activity in interest rate, foreign exchange, and energy products, reflecting market volatility stemming from changing interest rate expectations and global crude oil supply dynamics. The company also saw an improvement in its operating margin, which expanded to 60.2% from 58.5%. Net income attributable to CME Group rose by 24% to $330.4 million, leading to a diluted Earnings Per Share (EPS) of $0.98, up from $0.79 in the prior year's quarter. Management highlighted effective cost management, with total expenses increasing by a modest 4%, while also noting strategic financing activities, including the issuance of new debt and the early repurchase of existing notes. Overall, CME Group presented a strong financial performance, characterized by revenue growth, enhanced profitability, and robust cash flow from operations. The company appears well-positioned to navigate market dynamics, supported by its diversified revenue streams and ongoing efforts to manage expenses effectively. Investors can find reassurance in the company's ability to translate increased trading activity into higher profits.

Financial Highlights

46 data points

Beta

Revenue

$842.70M

Net Income

$330.40M

0.4% Net Margin

EPS (Diluted)

$0.98

Total Assets

$77.13B

Cash & Equivalents

$1.69B

Free Cash Flow

$387.50M

Financial Statements

Beta

Revenue	$842.70M
Operating Expenses	$335.40M
Operating Income	$507.30M
Net Income	$330.40M
EPS (Basic)	$0.98
EPS (Diluted)	$0.98
Shares Outstanding (Basic)	335.68M
Shares Outstanding (Diluted)	337.42M

Key Highlights

1Total revenues increased by 8% year-over-year to $842.7 million, driven by strong clearing and transaction fees.
2Clearing and transaction fees grew by 9% to $708.2 million, supported by a 10% increase in total contract volume.
3Net income attributable to CME Group surged by 24% to $330.4 million.
4Diluted Earnings Per Share (EPS) rose to $0.98 from $0.80 in the prior year's first quarter.
5Operating margin improved to 60.2% from 58.5% in the prior year's quarter.
6Cash flows from operating activities increased by 9% to $418.9 million.
7The company issued $750.0 million in new fixed rate notes and strategically repurchased $612.5 million in existing notes during and shortly after the quarter.

CME GROUP INC. Quarterly Report for Q1 Ended Mar 31, 2015

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions